United Therapeutics (UTHR) Misses Q2 EPS by 94c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $491.89 -1.15%
EPS Growth %: -10.1%
Financial Fact:
Other, net: 1M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -10.1%
Financial Fact:
Other, net: 1M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $6.41, $0.94 worse than the analyst estimate of $7.35. Revenue for the quarter came in at $798.6 million versus the consensus estimate of $804.98 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Senior Iranian Official To Reuters: Tehran Is Reviewing U.S. Response To Its Proposal To End Hostilities
- General Mills beats estimates as cost savings offset volumes
- Vuzix signs distribution deal with CommsPlus for Australia and Pacific
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
